South African Medical News

Back to Home Page

Print using browser
Omzyta Injection, measles, mumps and rubella virus vaccine live, (MSD)

msdlogo






Dear Healthcare Professional

MSD (Pty) Ltd wish to notify that OMZYTA® injection (measles, mumps and rubella virus vaccine live) is temporarily out of stock due to an increase in demand.

Stock supply will normalize from 30 June 2019.
  • This is a drug - read the leaflet carefully before use 
  • Ask your doctor or pharmacist for further information.
Patients should consult their doctors or healthcare professionals for advice on further management.

For full prescribing information refer to the package insert approved by the Medicines Regulatory Authority.

MSD thank you for your support and apologise for any inconvenience caused as a result of this temporary shortage of OMZYTA® injection.


MSD (Pty) Ltd. 117 - 16th Road, Halfway House, South Africa


S
2 OMZYTA'" powder and diluent for suspension for injection. Reg. No. 50/30.2/0576. Each 0,5 ml dose contains: a minimum of 1 000 CCID50 (50 % cell culture infectious dose) of measles virus; 12 500 CCID50 of mumps virus and 1 000 CCID50 of rubella virus when reconstituted.

You need to be logged in to see more details. Register Now!


Click here to visit the MSD website.....
Contact: Rhys Pritchard, Brand & Customer Manager: Vaccines
Telephone: +27 (0) 11 655 3000
E-mail: rhys.pritchard@merck.com
Date: Monday, April 15, 2019